Overview

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to explore if the combination of autologous NK cell infusion and chemotherapy can increase the therapeutic efficiency in the treatment of non-small cell lung cancer compared with chemotherapy alone.
Phase:
Phase 2
Details
Lead Sponsor:
Southwest Hospital, China
Treatments:
Carboplatin
Paclitaxel